Mathematical physiological models of type 1 diabetes (T1D) glucose-insulin dynamics have been of great help in designing and preliminary assessing new algorithm for glucose control. Derivation of models at the individual level is however difficult because of identifiability issues. Recently, fitting these models against data of real patients with T1D has been made possible by both the use of Bayesian estimation techniques and the availability of individual datasets including plasma glucose and insulin concentration samples gathered in clinical protocols. The aim of this work is to make a step further and develop a methodology able to estimate the parameters of T1D physiological models using easily accessible data only, i.e. continuous glucose monitoring (CGM) sensor, carbohydrate intakes (CHO), and exogenous insulin infusion (I) data. The methodology is tested on synthetic data of 100 patients generated by a composite model of glucose-insulin dynamics. To solve identifiability problems, a Bayesian approach numerically implemented by Markov Chain Monte Carlo (MCMC) has been used to obtain point estimates and confidence intervals of model unknown parameters exploiting a priori knowledge available from the literature. Results show goodness of model fit and acceptable precision of parameter estimates. The methodology is also successful in reconstructing of 'non-accessible' glucose-insulin fluxes, i.e. glucose rate of appearance and plasma insulin. These preliminary results encourage further development of this framework and its assessment in more challenging setups.

A Bayesian Framework to Identify Type 1 Diabetes Physiological Models Using Easily Accessible Patient Data

Cappon G.;Facchinetti A.;Sparacino G.;Favero
2019

Abstract

Mathematical physiological models of type 1 diabetes (T1D) glucose-insulin dynamics have been of great help in designing and preliminary assessing new algorithm for glucose control. Derivation of models at the individual level is however difficult because of identifiability issues. Recently, fitting these models against data of real patients with T1D has been made possible by both the use of Bayesian estimation techniques and the availability of individual datasets including plasma glucose and insulin concentration samples gathered in clinical protocols. The aim of this work is to make a step further and develop a methodology able to estimate the parameters of T1D physiological models using easily accessible data only, i.e. continuous glucose monitoring (CGM) sensor, carbohydrate intakes (CHO), and exogenous insulin infusion (I) data. The methodology is tested on synthetic data of 100 patients generated by a composite model of glucose-insulin dynamics. To solve identifiability problems, a Bayesian approach numerically implemented by Markov Chain Monte Carlo (MCMC) has been used to obtain point estimates and confidence intervals of model unknown parameters exploiting a priori knowledge available from the literature. Results show goodness of model fit and acceptable precision of parameter estimates. The methodology is also successful in reconstructing of 'non-accessible' glucose-insulin fluxes, i.e. glucose rate of appearance and plasma insulin. These preliminary results encourage further development of this framework and its assessment in more challenging setups.
2019
Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS
978-1-5386-1311-5
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3333988
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact